Vaxart (VXRT) is scheduled to report 4th quarter earnings on 03/14/2024, after the market closes.
Regarding Q4 estimates, Wall Street analysts expect Vaxart to post earnings of -$0.13 per share. Revenue expectations are pegged at $833 thousand. Last quarter, Vaxart beat earnings estimates, reporting EPS of -$0.11 on estimates of -$0.18. The stock rose by 5.11% the day after the last earnings release.
Year-to-date, VXRT stock has risen by 101.05%.
About Vaxart
Biota Holdings Ltd. operates as an anti infective drug development firm. The company was founded on October 2, 1985 and is headquartered in Notting Hil, Australia.
Stay up-to-date on earnings this week, with TipRanks’ Earnings Calendar.
